Keyla A. Perez

Parkville, VIC 3052, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Isomerized Aβ in the brain can distinguish the status of amyloidosis in the Alzheimer's disease spectrum.

Isomerized Aβ in the brain can distinguish the status of amyloidosis in the Alzheimer's disease spectrum.

Journal: Acta neuropathologica

Published: May 06, 2025

Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer's disease progression.

Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer's disease progression.

Journal: Nature communications

Published: November 01, 2023

Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.

Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.

Journal: Journal of neurochemistry

Published: July 25, 2022

Citrullination of Amyloid-β Peptides in Alzheimer's Disease.

Citrullination of Amyloid-β Peptides in Alzheimer's Disease.

Journal: ACS chemical neuroscience

Published: September 14, 2021

Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer's disease.

Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer's disease.

Journal: Brain communications

Published: November 05, 2020

Modulating Protein Phosphatase 2A Rescues Disease Phenotype in Neurodegenerative Tauopathies.

Modulating Protein Phosphatase 2A Rescues Disease Phenotype in Neurodegenerative Tauopathies.

Journal: ACS chemical neuroscience

Published: June 20, 2018

A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study.

A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study.

Journal: Alzheimer's & dementia (New York, N. Y.)

Published: December 05, 2017

Peripheral α-defensins 1 and 2 are elevated in Alzheimer's disease.

Peripheral α-defensins 1 and 2 are elevated in Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD

Published: November 20, 2014

High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer.

High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer.

Journal: Journal of Alzheimer's disease : JAD

Published: September 04, 2014

A commonly used Drosophila model of Alzheimer's disease generates an aberrant species of amyloid-β with an additional N-terminal glutamine residue.

A commonly used Drosophila model of Alzheimer's disease generates an aberrant species of amyloid-β with an additional N-terminal glutamine residue.

Journal: FEBS letters

Published: August 07, 2014

Anti-Aβ antibody target engagement: a response to Siemers et al.

Anti-Aβ antibody target engagement: a response to Siemers et al.

Journal: Acta neuropathologica

Published: August 06, 2014

Do current therapeutic anti-Aβ antibodies for Alzheimer's disease engage the target?

Do current therapeutic anti-Aβ antibodies for Alzheimer's disease engage the target?

Journal: Acta neuropathologica

Published: March 12, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026